Inhibikase Therapeutics Inc (IKT)

Investing Cash Flow

-$5.91M

Quarterly · Period ending: · USD

IKT logo

IKT Investing Cash Flow

Latest reported-$5.91M
IKT Quarterly Cash from Investing ($0.00 → -$5.91M)
High-resolution chart · PNG

IKT investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-5,908,702
-80,484,587
-98,847
-28,746,103
9,843,738
21,054,342
-38,761,725
2,526,111
2,543,227
-3,311,814
-2,115,595
17,061,224
2,549,879
-5,838,842
4,963,009
-20,925,628
-43,089
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.